Drug
Ctx131
Ctx131: highest development phase Phase 1, developed by CRISPR Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CRISPR Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CTX131 NCT05795595 | Phase 1 | Clear Cell Renal Cell Carcinoma |
| CTX131 NCT06492304 | Phase 1 | T Cell Lymphoma |
Latest
No recent events.
Follow Ctx131 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.